Global Psilocybin Assisted Therapy Market Research Report 2025(Status and Outlook)

September 2025 | 141 pages | ID: G50BCA0BA95FEN
Bosson Research

Abstracts

Psilocybin-assisted therapy refers to the controlled clinical use of psilocybin?a psychoactive compound found in certain mushrooms?in conjunction with psychological support, typically administered in a structured therapeutic setting to treat mental health conditions such as depression, anxiety, PTSD, and addiction.

The global Psilocybin Assisted Therapy market size was estimated at USD 375.0 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 16.50% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Psilocybin Assisted Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Psilocybin Assisted Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Psilocybin Assisted Therapy market.

Global Psilocybin Assisted Therapy Market: Market Segmentation Analysis


This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

MindMed
Compass Pathways
ATAI Life Sciences
Field Trip
DemeRx
Eleusis
Hikma Pharmaceuticals PLC
Pfizer
Verrian
Jazz Pharmaceuticals

Market Segmentation (by Type)

Natural
Synthetic

Market Segmentation (by Application)

Cluster Headaches
Anxiety Disorders
Psychiatric Disorders

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Psilocybin Assisted Therapy Market
Overview of the regional outlook of the Psilocybin Assisted Therapy Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Psilocybin Assisted Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Psilocybin Assisted Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Psilocybin Assisted Therapy
1.2 Key Market Segments
  1.2.1 Psilocybin Assisted Therapy Segment by Type
  1.2.2 Psilocybin Assisted Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PSILOCYBIN ASSISTED THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Psilocybin Assisted Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PSILOCYBIN ASSISTED THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Psilocybin Assisted Therapy Product Life Cycle
3.3 Global Psilocybin Assisted Therapy Sales by Manufacturers (2020-2025)
3.4 Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Psilocybin Assisted Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Psilocybin Assisted Therapy Market Competitive Situation and Trends
  3.8.1 Psilocybin Assisted Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Psilocybin Assisted Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PSILOCYBIN ASSISTED THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Psilocybin Assisted Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PSILOCYBIN ASSISTED THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Psilocybin Assisted Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy ? April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Psilocybin Assisted Therapy Market
5.7 ESG Ratings of Leading Companies

6 PSILOCYBIN ASSISTED THERAPY MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Psilocybin Assisted Therapy Sales Market Share by Type (2020-2025)
6.3 Global Psilocybin Assisted Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Psilocybin Assisted Therapy Price by Type (2020-2025)

7 PSILOCYBIN ASSISTED THERAPY MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Psilocybin Assisted Therapy Market Sales by Application (2020-2025)
7.3 Global Psilocybin Assisted Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Psilocybin Assisted Therapy Sales Growth Rate by Application (2020-2025)

8 PSILOCYBIN ASSISTED THERAPY MARKET SALES BY REGION

8.1 Global Psilocybin Assisted Therapy Sales by Region
  8.1.1 Global Psilocybin Assisted Therapy Sales by Region
  8.1.2 Global Psilocybin Assisted Therapy Sales Market Share by Region
8.2 Global Psilocybin Assisted Therapy Market Size by Region
  8.2.1 Global Psilocybin Assisted Therapy Market Size by Region
  8.2.2 Global Psilocybin Assisted Therapy Market Size Market Share by Region
8.3 North America
  8.3.1 North America Psilocybin Assisted Therapy Sales by Country
  8.3.2 North America Psilocybin Assisted Therapy Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Psilocybin Assisted Therapy Sales by Country
  8.4.2 Europe Psilocybin Assisted Therapy Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Psilocybin Assisted Therapy Sales by Region
  8.5.2 Asia Pacific Psilocybin Assisted Therapy Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Psilocybin Assisted Therapy Sales by Country
  8.6.2 South America Psilocybin Assisted Therapy Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Psilocybin Assisted Therapy Sales by Region
  8.7.2 Middle East and Africa Psilocybin Assisted Therapy Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PSILOCYBIN ASSISTED THERAPY MARKET PRODUCTION BY REGION

9.1 Global Production of Psilocybin Assisted Therapy by Region(2020-2025)
9.2 Global Psilocybin Assisted Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Psilocybin Assisted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Psilocybin Assisted Therapy Production
  9.4.1 North America Psilocybin Assisted Therapy Production Growth Rate (2020-2025)
  9.4.2 North America Psilocybin Assisted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Psilocybin Assisted Therapy Production
  9.5.1 Europe Psilocybin Assisted Therapy Production Growth Rate (2020-2025)
  9.5.2 Europe Psilocybin Assisted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Psilocybin Assisted Therapy Production (2020-2025)
  9.6.1 Japan Psilocybin Assisted Therapy Production Growth Rate (2020-2025)
  9.6.2 Japan Psilocybin Assisted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Psilocybin Assisted Therapy Production (2020-2025)
  9.7.1 China Psilocybin Assisted Therapy Production Growth Rate (2020-2025)
  9.7.2 China Psilocybin Assisted Therapy Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 MindMed
  10.1.1 MindMed Basic Information
  10.1.2 MindMed Psilocybin Assisted Therapy Product Overview
  10.1.3 MindMed Psilocybin Assisted Therapy Product Market Performance
  10.1.4 MindMed Business Overview
  10.1.5 MindMed SWOT Analysis
  10.1.6 MindMed Recent Developments
10.2 Compass Pathways
  10.2.1 Compass Pathways Basic Information
  10.2.2 Compass Pathways Psilocybin Assisted Therapy Product Overview
  10.2.3 Compass Pathways Psilocybin Assisted Therapy Product Market Performance
  10.2.4 Compass Pathways Business Overview
  10.2.5 Compass Pathways SWOT Analysis
  10.2.6 Compass Pathways Recent Developments
10.3 ATAI Life Sciences
  10.3.1 ATAI Life Sciences Basic Information
  10.3.2 ATAI Life Sciences Psilocybin Assisted Therapy Product Overview
  10.3.3 ATAI Life Sciences Psilocybin Assisted Therapy Product Market Performance
  10.3.4 ATAI Life Sciences Business Overview
  10.3.5 ATAI Life Sciences SWOT Analysis
  10.3.6 ATAI Life Sciences Recent Developments
10.4 Field Trip
  10.4.1 Field Trip Basic Information
  10.4.2 Field Trip Psilocybin Assisted Therapy Product Overview
  10.4.3 Field Trip Psilocybin Assisted Therapy Product Market Performance
  10.4.4 Field Trip Business Overview
  10.4.5 Field Trip Recent Developments
10.5 DemeRx
  10.5.1 DemeRx Basic Information
  10.5.2 DemeRx Psilocybin Assisted Therapy Product Overview
  10.5.3 DemeRx Psilocybin Assisted Therapy Product Market Performance
  10.5.4 DemeRx Business Overview
  10.5.5 DemeRx Recent Developments
10.6 Eleusis
  10.6.1 Eleusis Basic Information
  10.6.2 Eleusis Psilocybin Assisted Therapy Product Overview
  10.6.3 Eleusis Psilocybin Assisted Therapy Product Market Performance
  10.6.4 Eleusis Business Overview
  10.6.5 Eleusis Recent Developments
10.7 Hikma Pharmaceuticals PLC
  10.7.1 Hikma Pharmaceuticals PLC Basic Information
  10.7.2 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Overview
  10.7.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Market Performance
  10.7.4 Hikma Pharmaceuticals PLC Business Overview
  10.7.5 Hikma Pharmaceuticals PLC Recent Developments
10.8 Pfizer
  10.8.1 Pfizer Basic Information
  10.8.2 Pfizer Psilocybin Assisted Therapy Product Overview
  10.8.3 Pfizer Psilocybin Assisted Therapy Product Market Performance
  10.8.4 Pfizer Business Overview
  10.8.5 Pfizer Recent Developments
10.9 Verrian
  10.9.1 Verrian Basic Information
  10.9.2 Verrian Psilocybin Assisted Therapy Product Overview
  10.9.3 Verrian Psilocybin Assisted Therapy Product Market Performance
  10.9.4 Verrian Business Overview
  10.9.5 Verrian Recent Developments
10.10 Jazz Pharmaceuticals
  10.10.1 Jazz Pharmaceuticals Basic Information
  10.10.2 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Overview
  10.10.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Market Performance
  10.10.4 Jazz Pharmaceuticals Business Overview
  10.10.5 Jazz Pharmaceuticals Recent Developments

11 PSILOCYBIN ASSISTED THERAPY MARKET FORECAST BY REGION

11.1 Global Psilocybin Assisted Therapy Market Size Forecast
11.2 Global Psilocybin Assisted Therapy Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Psilocybin Assisted Therapy Market Size Forecast by Country
  11.2.3 Asia Pacific Psilocybin Assisted Therapy Market Size Forecast by Region
  11.2.4 South America Psilocybin Assisted Therapy Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Psilocybin Assisted Therapy by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)

12.1 Global Psilocybin Assisted Therapy Market Forecast by Type (2026-2033)
  12.1.1 Global Forecasted Sales of Psilocybin Assisted Therapy by Type (2026-2033)
  12.1.2 Global Psilocybin Assisted Therapy Market Size Forecast by Type (2026-2033)
  12.1.3 Global Forecasted Price of Psilocybin Assisted Therapy by Type (2026-2033)
12.2 Global Psilocybin Assisted Therapy Market Forecast by Application (2026-2033)
  12.2.1 Global Psilocybin Assisted Therapy Sales (K MT) Forecast by Application
  12.2.2 Global Psilocybin Assisted Therapy Market Size (M USD) Forecast by Application (2026-2033)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Psilocybin Assisted Therapy Market Size Comparison by Region (M USD)
Table 5. Global Psilocybin Assisted Therapy Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Psilocybin Assisted Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psilocybin Assisted Therapy as of 2024)
Table 10. Global Market Psilocybin Assisted Therapy Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Psilocybin Assisted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Psilocybin Assisted Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Psilocybin Assisted Therapy Sales by Type (K MT)
Table 26. Global Psilocybin Assisted Therapy Market Size by Type (M USD)
Table 27. Global Psilocybin Assisted Therapy Sales (K MT) by Type (2020-2025)
Table 28. Global Psilocybin Assisted Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Psilocybin Assisted Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Psilocybin Assisted Therapy Market Size Share by Type (2020-2025)
Table 31. Global Psilocybin Assisted Therapy Price (USD/KG) by Type (2020-2025)
Table 32. Global Psilocybin Assisted Therapy Sales (K MT) by Application
Table 33. Global Psilocybin Assisted Therapy Market Size by Application
Table 34. Global Psilocybin Assisted Therapy Sales by Application (2020-2025) & (K MT)
Table 35. Global Psilocybin Assisted Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Psilocybin Assisted Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Psilocybin Assisted Therapy Market Share by Application (2020-2025)
Table 38. Global Psilocybin Assisted Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Psilocybin Assisted Therapy Sales by Region (2020-2025) & (K MT)
Table 40. Global Psilocybin Assisted Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Psilocybin Assisted Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Psilocybin Assisted Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K MT)
Table 44. North America Psilocybin Assisted Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K MT)
Table 46. Europe Psilocybin Assisted Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Psilocybin Assisted Therapy Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Psilocybin Assisted Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Psilocybin Assisted Therapy Sales by Country (2020-2025) & (K MT)
Table 50. South America Psilocybin Assisted Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Psilocybin Assisted Therapy Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Psilocybin Assisted Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Psilocybin Assisted Therapy Production (K MT) by Region(2020-2025)
Table 54. Global Psilocybin Assisted Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Psilocybin Assisted Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Psilocybin Assisted Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Psilocybin Assisted Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Psilocybin Assisted Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Psilocybin Assisted Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Psilocybin Assisted Therapy Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. MindMed Basic Information
Table 62. MindMed Psilocybin Assisted Therapy Product Overview
Table 63. MindMed Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. MindMed Business Overview
Table 65. MindMed SWOT Analysis
Table 66. MindMed Recent Developments
Table 67. Compass Pathways Basic Information
Table 68. Compass Pathways Psilocybin Assisted Therapy Product Overview
Table 69. Compass Pathways Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Compass Pathways Business Overview
Table 71. Compass Pathways SWOT Analysis
Table 72. Compass Pathways Recent Developments
Table 73. ATAI Life Sciences Basic Information
Table 74. ATAI Life Sciences Psilocybin Assisted Therapy Product Overview
Table 75. ATAI Life Sciences Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. ATAI Life Sciences Business Overview
Table 77. ATAI Life Sciences SWOT Analysis
Table 78. ATAI Life Sciences Recent Developments
Table 79. Field Trip Basic Information
Table 80. Field Trip Psilocybin Assisted Therapy Product Overview
Table 81. Field Trip Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. Field Trip Business Overview
Table 83. Field Trip Recent Developments
Table 84. DemeRx Basic Information
Table 85. DemeRx Psilocybin Assisted Therapy Product Overview
Table 86. DemeRx Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. DemeRx Business Overview
Table 88. DemeRx Recent Developments
Table 89. Eleusis Basic Information
Table 90. Eleusis Psilocybin Assisted Therapy Product Overview
Table 91. Eleusis Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. Eleusis Business Overview
Table 93. Eleusis Recent Developments
Table 94. Hikma Pharmaceuticals PLC Basic Information
Table 95. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Overview
Table 96. Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. Hikma Pharmaceuticals PLC Business Overview
Table 98. Hikma Pharmaceuticals PLC Recent Developments
Table 99. Pfizer Basic Information
Table 100. Pfizer Psilocybin Assisted Therapy Product Overview
Table 101. Pfizer Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Verrian Basic Information
Table 105. Verrian Psilocybin Assisted Therapy Product Overview
Table 106. Verrian Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Verrian Business Overview
Table 108. Verrian Recent Developments
Table 109. Jazz Pharmaceuticals Basic Information
Table 110. Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Overview
Table 111. Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Jazz Pharmaceuticals Business Overview
Table 113. Jazz Pharmaceuticals Recent Developments
Table 114. Global Psilocybin Assisted Therapy Sales Forecast by Region (2026-2033) & (K MT)
Table 115. Global Psilocybin Assisted Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Psilocybin Assisted Therapy Sales Forecast by Country (2026-2033) & (K MT)
Table 117. North America Psilocybin Assisted Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Psilocybin Assisted Therapy Sales Forecast by Country (2026-2033) & (K MT)
Table 119. Europe Psilocybin Assisted Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Psilocybin Assisted Therapy Sales Forecast by Region (2026-2033) & (K MT)
Table 121. Asia Pacific Psilocybin Assisted Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Psilocybin Assisted Therapy Sales Forecast by Country (2026-2033) & (K MT)
Table 123. South America Psilocybin Assisted Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Psilocybin Assisted Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Psilocybin Assisted Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Psilocybin Assisted Therapy Sales Forecast by Type (2026-2033) & (K MT)
Table 127. Global Psilocybin Assisted Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Psilocybin Assisted Therapy Price Forecast by Type (2026-2033) & (USD/KG)
Table 129. Global Psilocybin Assisted Therapy Sales (K MT) Forecast by Application (2026-2033)
Table 130. Global Psilocybin Assisted Therapy Market Size Forecast by Application (2026-2033) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Psilocybin Assisted Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Psilocybin Assisted Therapy Market Size (M USD), 2024-2033
Figure 5. Global Psilocybin Assisted Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Psilocybin Assisted Therapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Psilocybin Assisted Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Psilocybin Assisted Therapy Product Life Cycle
Figure 13. Psilocybin Assisted Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Psilocybin Assisted Therapy Revenue Share by Manufacturers in 2024
Figure 15. Psilocybin Assisted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Psilocybin Assisted Therapy Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Psilocybin Assisted Therapy Revenue in 2024
Figure 18. Industry Chain Map of Psilocybin Assisted Therapy
Figure 19. Global Psilocybin Assisted Therapy Market PEST Analysis
Figure 20. Global Psilocybin Assisted Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Psilocybin Assisted Therapy Market Share by Type
Figure 27. Sales Market Share of Psilocybin Assisted Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Psilocybin Assisted Therapy by Type in 2024
Figure 29. Market Size Share of Psilocybin Assisted Therapy by Type (2020-2025)
Figure 30. Market Size Share of Psilocybin Assisted Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Psilocybin Assisted Therapy Market Share by Application
Figure 33. Global Psilocybin Assisted Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Psilocybin Assisted Therapy Sales Market Share by Application in 2024
Figure 35. Global Psilocybin Assisted Therapy Market Share by Application (2020-2025)
Figure 36. Global Psilocybin Assisted Therapy Market Share by Application in 2024
Figure 37. Global Psilocybin Assisted Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Psilocybin Assisted Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Psilocybin Assisted Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Psilocybin Assisted Therapy Sales Market Share by Country in 2024
Figure 43. North America Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Psilocybin Assisted Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Psilocybin Assisted Therapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Psilocybin Assisted Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Psilocybin Assisted Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Psilocybin Assisted Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Psilocybin Assisted Therapy Sales Market Share by Country in 2024
Figure 53. Europe Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Psilocybin Assisted Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Psilocybin Assisted Therapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Psilocybin Assisted Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Psilocybin Assisted Therapy Market Size Market Share by Region in 2024
Figure 68. China Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Psilocybin Assisted Therapy Sales and Growth Rate (K MT)
Figure 79. South America Psilocybin Assisted Therapy Sales Market Share by Country in 2024
Figure 80. South America Psilocybin Assisted Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Psilocybin Assisted Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Psilocybin Assisted Therapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Psilocybin Assisted Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Psilocybin Assisted Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Psilocybin Assisted Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Psilocybin Assisted Therapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Psilocybin Assisted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Psilocybin Assisted Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Psilocybin Assisted Therapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Psilocybin Assisted Therapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Psilocybin Assisted Therapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Psilocybin Assisted Therapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Psilocybin Assisted Therapy Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Psilocybin Assisted Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Psilocybin Assisted Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Psilocybin Assisted Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Psilocybin Assisted Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Psilocybin Assisted Therapy Market Share Forecast by Application (2026-2033)